| Authors: |
O'Reilly EM; Memorial Sloan Kettering Cancer Center, New York., Wainberg ZA; Jonsson Comprehensive Cancer Center, University of California, Los Angeles, Los Angeles., Hendifar AE; Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles., Borad MJ; Department of Oncology, Mayo Clinic, Phoenix, AZ., Pietrantonio F; Medical Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan., Pant S; M.D. Anderson Cancer Center, Houston., Hammel P; Hôpital Paul-Brousse, Assistance Publique-Hôpitaux de Paris, Université Paris-Saclay, Villejuif, France., Cremolini C; Azienda Ospedaliero-Universitaria Pisana and Università di Pisa, Pisa, Italy., Manji GA; Herbert Irving Comprehensive Cancer Center, Columbia University Irving Medical Center, New York., Oberstein PE; Department of Hematology-Oncology, NYU Langone Health, New York University, New York., Garrido-Laguna I; Huntsman Cancer Institute, University of Utah, Salt Lake City., Springfeld C; Heidelberg University Hospital, National Center for Tumor Diseases, Heidelberg, Germany., Azad NS; Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore., Ueno M; Department of Gastroenterology, Kanagawa Cancer Center, Yokohama, Japan., Chui SY; Revolution Medicines, Redwood City, CA., Zhang Y; Revolution Medicines, Redwood City, CA., Patel H; Revolution Medicines, Redwood City, CA., Lee Y; Revolution Medicines, Redwood City, CA., Salman Z; Revolution Medicines, Redwood City, CA., Wolpin BM; Hale Family Center for Pancreatic Cancer Research, Dana-Farber Cancer Institute, Boston. |
